A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks
Clinical trial NCT00634790 · TERMINATED
Trial details
- NCT number
- NCT00634790
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.